The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 25, 2022

Filed:

Nov. 30, 2017
Applicants:

Kepler Diagnostics, Inc., Simi Valley, CA (US);

Katholieke Universiteit Leuven, Leuven, BE;

Inventors:

Avinoam Dukler, Newbury Park, CA (US);

Randy Ringold, Simi Valley, CA (US);

Severine Vermeire, Leuven, BE;

Magali De Bruyn, Leuven, BE;

Ghislain Opdenakker, Leuven, BE;

Assignees:

Glycominds, LLC, Simi Valley, GA (US);

Katholieke Universiteit Leuven, Leuven, BE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/564 (2006.01); G01N 33/53 (2006.01); G01N 33/74 (2006.01); G01N 33/68 (2006.01); G01N 33/569 (2006.01); G16H 50/30 (2018.01);
U.S. Cl.
CPC ...
G01N 33/564 (2013.01); G01N 33/53 (2013.01); G01N 33/56972 (2013.01); G01N 33/68 (2013.01); G01N 33/74 (2013.01); G01N 2333/4737 (2013.01); G01N 2800/065 (2013.01); G01N 2800/52 (2013.01); G16H 50/30 (2018.01);
Abstract

Mucosal healing is an indication to the disease activity level in patients affected by inflammatory bowel diseases, and it is thus far mainly monitored by endoscopy. Instead or in addition to endoscopy, the invention provides blood test using biomarkers and an index that allows a practitioner to assess the status of mucosal healing, to change or adapt dosage of treatment and to predict which patient will become responder versus non-responder to treatment as assessed by endoscopy. While none of neutrophils cell count, c-reactive protein (CRP), Human type of Cathelicidin (LL-37), or Chitinase 3-like 1 (CHI3L1) alone is able to provide an assessment means of mucosal healing, the invention provides a novel combination of the levels of these biomarkers to assess the level of mucosal healing in relation to endoscopic healing.


Find Patent Forward Citations

Dukler, Avinoam. (2022). Biomarker test and method for assessing mucosal healing in response to treatment of ulcerative colitis (U.S. Patent No. 11480569). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11480569

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…